Skip to content
Try Mental Wellness – Lifestyle
Author:
XORTX Therapeutics Inc.
XORTX Announces Director Resignation
July 31, 2026
XORTX Appoints New Director
July 29, 2026
XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO
June 15, 2026
XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange
June 12, 2026
XORTX Announces Closing of US$5 Million Public Offering
May 19, 2026
XORTX Announces US$5 Million Public Offering
May 14, 2026
XORTX Meets Nasdaq Continued Listing Requirements
April 21, 2026
XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset
April 14, 2026
XORTX Confirms Effective Date of Share Consolidation
April 2, 2026
XORTX Announces Results of Annual and Special Meeting of Shareholders
March 27, 2026
1
2
Next Page
→